4.3 Review

Remdesivir for the treatment of COVID 19: review of the pharmacological properties, safety and clinical effectiveness

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Compassionate Use of Remdesivir in Pregnant Women With Severe Coronavirus Disease 2019

Richard M. Burwick et al.

Summary: The study demonstrates high recovery rates and a low incidence of serious adverse events among 86 pregnant and postpartum women with severe COVID-19 who received compassionate use remdesivir.

CLINICAL INFECTIOUS DISEASES (2021)

Article Virology

Effectiveness of remdesivir for the treatment of hospitalized COVID-19 persons: A network meta-analysis

Yawen Jiang et al.

Summary: The study aimed to synthesize available RCT evidence on the effectiveness of remdesivir for treating hospitalized COVID-19 patients using network meta-analyses. Both the 10-day and 5-day remdesivir regimens were associated with higher odds of clinical improvement and recovery compared to a placebo. This suggests that remdesivir may have clinical benefits for hospitalized COVID-19 patients.

JOURNAL OF MEDICAL VIROLOGY (2021)

Review Medicine, Research & Experimental

Remdesivir: A potential game-changer or just a myth? A systematic review and meta-analysis

Dhan Bahadur Shrestha et al.

Summary: Remdesivir has shown better efficacy in treating COVID-19, with reduced mortality, improved clinical recovery, and higher discharge rates. However, a longer course of remdesivir may lead to more serious adverse effects and drug discontinuation compared to a shorter course.

LIFE SCIENCES (2021)

Article Medicine, General & Internal

Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results

Summary: The authors of the study reported the interim results of using four repurposed antiviral drugs (remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a) in hospitalized COVID-19 patients. The study showed that these drug regimens had little or no effect on overall mortality, initiation of ventilation, and duration of hospital stay.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Virology

Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis

Hozaifa Khalil Elsawah et al.

Summary: The systematic review and meta-analysis found that remdesivir increased the recovery rate for severe and moderate Covid-19 patients, with over 50% improvement on day 14, and decreased the mortality rate by 36%, but the effect decreased by day 28.

REVIEWS IN MEDICAL VIROLOGY (2021)

Article Infectious Diseases

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19

Adarsh Bhimraj et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Public, Environmental & Occupational Health

Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020

Stephanie Bialek et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Waradon Sungnak et al.

NATURE MEDICINE (2020)

Article Medicine, General & Internal

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Compassionate Use of Remdesivir for Patients with Severe Covid-19

J. Grein et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Pediatrics

Epidemiology of COVID-19 Among Children in China

Yuanyuan Dong et al.

PEDIATRICS (2020)

Editorial Material Obstetrics & Gynecology

Use of remdesivir for pregnant patients with severe novel coronavirus disease 2019

Irogue Igbinosa et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2020)

Article Medicine, Research & Experimental

Safety, Tolerability, and Pharmacokinetics of Remdesivir, An Antiviral for Treatment of COVID-19, in Healthy Subjects

Rita Humeniuk et al.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)

Review Gastroenterology & Hepatology

Abnormal Liver Function Tests in Patients WithCOVID-19: Relevance and Potential Pathogenesis

Anna Bertolini et al.

HEPATOLOGY (2020)

Review Medicine, General & Internal

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review

W. Joost Wiersinga et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Pediatrics

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

Florian Goetzinger et al.

LANCET CHILD & ADOLESCENT HEALTH (2020)

Article Obstetrics & Gynecology

Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19)

Mariam Naqvi et al.

OBSTETRICS AND GYNECOLOGY (2020)

Article Medicine, General & Internal

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial

Christoph D. Spinner et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Infectious Diseases

Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2

Kathleen Chiotos et al.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)

Article Medicine, General & Internal

A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics

Sabue Mulangu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Multidisciplinary Sciences

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses

Michael K. Lo et al.

SCIENTIFIC REPORTS (2017)

Article Medicine, General & Internal

Late Ebola virus relapse causing meningoencephalitis: a case report

Michael Jacobs et al.

LANCET (2016)